Few new chemicals are in development for malaria vector control

NewsGuard 100/100 Score

"This issue has been building for some time. It is really no surprise as insects have become resistant to nearly all insecticides given time and selection pressure. Few new chemicals are in development for malaria vector control, because there is little profit to be made by the poorest of the world's poor — who feel the brunt of the malaria burden.

"There is a tremendous need to identify new ways of controlling malaria vectors that are practical, low cost, and sustainable or even looking at the existing technology with a new perspective toward using them in ways that prolong their efficacy. Unfortunately, this type of practical research is not viewed as 'sexy science' and it is nearly impossible to obtain funding by the large agencies to support it.

"Another critical need is to sincerely train and provide support for in-country, field-based scientists and technicians to manage resistance development. Many western scientists pay lip service to this notion, but few really devote effort and resources to make it happen. Training and enabling in-country scientists will lead to sustainability and independence for countries with high malaria burdens instead of helplessly relying on the ebb and flow of philanthropic dollars."

Source: Cornell University

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show